148 related articles for article (PubMed ID: 6401828)
1. Amyloid proteins, precursors, mediator, and enhancer.
Cohen AS; Shirahama T; Sipe JD; Skinner M
Lab Invest; 1983 Jan; 48(1):1-4. PubMed ID: 6401828
[No Abstract] [Full Text] [Related]
2. Amyloidosis: a familiar problem in the light of current pathogenetic developments.
Kisilevsky R
Lab Invest; 1983 Oct; 49(4):381-90. PubMed ID: 6353059
[No Abstract] [Full Text] [Related]
3. Further characterization of amyloid-enhancing factor.
Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
[TBL] [Abstract][Full Text] [Related]
4. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
Maeda S
Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
[TBL] [Abstract][Full Text] [Related]
5. Targeted treatment for amyloidosis.
Pepys-Vered ME; Pepys MB
Isr Med Assoc J; 2014 May; 16(5):277-80. PubMed ID: 24979830
[No Abstract] [Full Text] [Related]
6. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
Westermark GT; Westermark P
FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
[TBL] [Abstract][Full Text] [Related]
8. Association of apolipoprotein E with murine amyloid A protein amyloid.
Kindy MS; King AR; Perry G; de Beer MC; de Beer FC
Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin allotypes are not involved in systemic amyloidosis.
Ockhuizen T; Westra H; Bijzet J; Post J; van Leeuwen M; van Rijswijk M
J Rheumatol; 1985 Aug; 12(4):742-6. PubMed ID: 3932652
[TBL] [Abstract][Full Text] [Related]
10. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
11. A serum AA-like protein as a common constituent of secondary amyloid fibrils.
Westermark P; Sletten K
Clin Exp Immunol; 1982 Sep; 49(3):725-31. PubMed ID: 7172504
[TBL] [Abstract][Full Text] [Related]
12. [Current theories on the pathogenesis of amyloidosis].
Kordecki H
Wiad Lek; 1982 Oct; 35(18):1171-6. PubMed ID: 6817524
[No Abstract] [Full Text] [Related]
13. Biochemical evidence for the biphasic development of experimental amyloidosis.
Sipe JD; McAdam KP; Uchino F
Lab Invest; 1978 Jan; 38(1):110-4. PubMed ID: 621923
[No Abstract] [Full Text] [Related]
14. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
Pepys MB
Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
[TBL] [Abstract][Full Text] [Related]
15. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice.
Ganowiak K; Hultman P; Engström U; Gustavsson A; Westermark P
Biochem Biophys Res Commun; 1994 Feb; 199(1):306-12. PubMed ID: 8123028
[TBL] [Abstract][Full Text] [Related]
16. [AL- and AA-amyloidosis (the status of the problem)].
Kochubeĭ LN; Vinogradova OM; Serov VV; Vasil'eva NA; Tomas NIu
Klin Med (Mosk); 1988 Aug; 66(8):7-16. PubMed ID: 3057283
[No Abstract] [Full Text] [Related]
17. [Detection of monoclonal plasma cells in bone marrow and spleen of primary amyloidosis].
Katayama Y; Sakai A; Nobuyoshi M; Shimomura T; Kimura A
Rinsho Ketsueki; 2001 Sep; 42(9):705-9. PubMed ID: 11680983
[TBL] [Abstract][Full Text] [Related]
18. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
19. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis.
Arbustini E; Verga L; Concardi M; Palladini G; Obici L; Merlini G
Amyloid; 2002 Jun; 9(2):108-14. PubMed ID: 12440483
[TBL] [Abstract][Full Text] [Related]
20. Toward understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition.
Bellotti V; Merlini G
Nephrol Dial Transplant; 1996 Sep; 11(9):1708-11. PubMed ID: 8918605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
